ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Washington » Internal Medicine

Top Internal Medicine Prescribers in Washington

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CARYN JACKSON MD

Internal Medicine

3,976

$203K

222
120 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $56

JULIE RAEKES MD

Internal Medicine

1,614

$189K

122
97 are 65+

N/A

16%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$117
Average prescription price

Avg: $56

MEREDITH HEICK MD

Internal Medicine

1,373

$141K

123
97 are 65+

N/A

16%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$103
Average prescription price

Avg: $56

MARTI LIDDELL M.D.

Internal Medicine

2,243

$108K

252
230 are 65+

N/A

9%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $56

YUNYU CAO MD

Internal Medicine

1,713

$100K

195
154 are 65+

N/A

7%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $56

JAMES MARTIN MD

Internal Medicine

1,807

$98.7K

181
166 are 65+

N/A

6%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $56

ROOHI WANI M.D.

Internal Medicine

1,742

$91.4K

206
186 are 65+

N/A

6%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $56

KENDRA GIL M.D.

Internal Medicine

1,300

$82.7K

145
139 are 65+

N/A
N/A

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$64
Average prescription price

Avg: $56

PRATIMA SHARMA MD

Internal Medicine

984

$42K

81
62 are 65+

N/A
N/A

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$43
Average prescription price

Avg: $56

BRYAN JOHNSON M.D.

Internal Medicine

21,611

$1.04M

629
519 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

22%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $56

SU YONG PAK M.D.

Internal Medicine

15,201

$939K

547
507 are 65+

3%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $56

SHWETA BALIGA MD

Internal Medicine

14,770

$838K

520
431 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $56

WALLACE HODGES MD

Internal Medicine

9,073

$764K

287
167 are 65+

38%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$84
Average prescription price

Avg: $56

FLOYD SMITH M.D.

Internal Medicine

10,518

$648K

332
307 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

25%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $56

JOHN HAMILL MD

Internal Medicine

8,193

$617K

300
202 are 65+

21%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$75
Average prescription price

Avg: $56

GNANARANJITHA PILLAI MD

Internal Medicine

11,795

$614K

552
490 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $56

JOHN FLOYD MD

Internal Medicine

10,963

$588K

506
466 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $56

KENNETH SHIBATA MD

Internal Medicine

11,660

$573K

652
487 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $56

STANLEY LING MD

Internal Medicine

7,342

$546K

357
297 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$74
Average prescription price

Avg: $56

BRADLEY HARRIS M.D.

Internal Medicine

8,784

$542K

669
593 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $56

JOHN MITCHELL MD

Internal Medicine

11,641

$539K

637
522 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $56

I JEN CHEN MD

Internal Medicine

11,281

$535K

374
365 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $56

ROBERT WIGERT MD

Internal Medicine

11,351

$534K

476
397 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $56

SANDRA DIANGI MD

Internal Medicine

7,301

$497K

481
426 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$68
Average prescription price

Avg: $56

MYTHILI RAMACHANDRAN M.D.

Internal Medicine

9,940

$491K

338
265 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

22%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank